Scenic Biotech
Scenic Biotech is a developer of genomics and immunotherapy technology founded in 2017 by Thijn Brummelkamp.
6
Funding Rounds
$87.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Th*** Br********* | - | - | |
| Se******* Ni**** | - | - |
Funding
Funding series
Funding Series Analysis
The company Scenic Biotech has raised a total of $76m in funding over 6 rounds.
Key Insights:
- Scenic Biotech Series A round, March 2022: $31m
- Scenic Biotech March 2022 Series A Funding Round: $31m
- Scenic Biotech June 2017 Series A Funding Round: $7m
- Scenic Biotech June 2017 Series A Funding Round: $7m
- Scenic Biotech B.V. Grant (money), June 2020: $3.71m
- Scenic Biotech B.V. Series A round, June 2017: $7.78m
Scenic Biotech Series A round, March 2022
$31m
Scenic Biotech March 2022 Series A Funding Round
$31m
Scenic Biotech June 2017 Series A Funding Round
$7m
Scenic Biotech June 2017 Series A Funding Round
$7m
Scenic Biotech B.V. Grant (money), June 2020
$3.71m
Scenic Biotech B.V. Series A round, June 2017
$7.78m
Industries
Scenic Biotech is active in the following industries: